Inactive Instrument

News EXACT Therapeutics AS Oslo Bors

Equities

NO0010852213

Summary

Unlock all the news: Be the first to know and act before the market!

Financial calendar	05-23	AQ
EXACT Therapeutics : Successful placement of NOK 25 million share issue	04-25	PU
EXACT Therapeutics AS Reports Earnings Results for the Full Year Ended December 31, 2023	04-18	CI
Additional promising clinical data from EXACT Therapeutics' ongoing ACTIVATE study presented at AACR Annual Meeting	04-10	AQ
EXACT Therapeutics to Present at 2024 American Association for Cancer Research (AACR) Annual Meeting	03-06	AQ
EXACT Therapeutics AS - Share capital increase registered	12-20	AQ
EXACT Therapeutics presenting at DNB Nordic Healthcare conference December 14	12-14	AQ
EXACT Therapeutics : announces successful placement of NOK 25 million share issue	12-01	PU
EXACT Therapeutics AS: Primary insider notices	12-01	AQ
EXACT Therapeutics AS: Private placement successfully placed	11-30	AQ
EXACT Therapeutics AS: Contemplated Private Placement	11-30	AQ
Exact Therapeutics Wins Regulatory Approvals for Patient Recruitment in Dose Expansion Study	23-10-31	MT
EXACT Therapeutics receives regulatory approval to start recruitment of patients at Oslo University hospital	23-10-31	AQ
EXACT Therapeutics AS - Issuance of share options	23-10-16	AQ
EXACT Therapeutics CEO Dr Per Walday to participate in international Drug Delivery panel	23-10-12	AQ
EXACT Therapeutics AS Reports Earnings Results for the Half Year Ended June 30, 2023	23-09-28	CI
EXACT Therapeutics : Interim Report 2023	23-09-28	PU
EXACT Therapeutics announces first half 2023 interim results	23-09-28	AQ
EXACT Therapeutics announces appointment of Caspar Foghsgaard as SVP Commercial & Business Development	23-09-27	AQ
EXACT Therapeutics AS Announces Appointment of Caspar Foghsgaard as SVP Commercial & Business Development Effective 1 November 2023	23-09-27	CI

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

News EXACT Therapeutics AS Oslo Bors

Equities

NO0010852213

Summary

Filters